SynthesisArquivos brasileiros de cardiologia2015
Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review.
Synthesis in Arquivos brasileiros de cardiologia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- Safety and efficacy of new oral anticoagulants compared to those of warfarin in AF patients with cancer: a meta-analysis of randomized clinical trials and observational studies.European journal of clinical pharmacology · 2021Pooled it
- Association between atrial fibrillation and Helicobacter pylori.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Pooled it
- Hidden Beats: Detection of Subclinical Atrial Fibrillation Using Questionnaires in Young Adults and Its Cardiovascular Risk Profile.Juntendo medical journal · 2026Article
- Risk of Death From Various Causes According to Prevalent Atrial Fibrillation: A Nationwide Population-Based Study.Journal of Korean medical science · 2024Article
- Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: AInternational journal of cardiology. Heart & vasculature · 2024Review
- Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation.Arquivos de neuro-psiquiatria · 2023Article
- Long-Term Sports Practice and Atrial Fibrillation: An Updated Review of a Complex Relationship.Journal of cardiovascular development and disease · 2023Review
- Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives.Arquivos brasileiros de cardiologia · 2022Review
- 4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.European journal of clinical investigation · 2022Article
- Use of antithrombotics at the end of life: an in-depth chart review study.BMC palliative care · 2021Article
- Atrial fibrillation following low voltage electrical injury.BMJ case reports · 2021Article
- Prediction of Recurrent Atrial Tachyarrhythmia After Receiving Atrial Flutter Ablation in Patients With Prior Cardiac Surgery for Valvular Heart Disease.Frontiers in cardiovascular medicine · 2021Article
- Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.The journals of gerontology. Series A, Biological sciences and medical sciences · 2020Article
- Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort study.Diabetes, obesity & metabolism · 2020Article
- Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review.Journal of community hospital internal medicine perspectives · 2020Review
- Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology.Journal of clinical medicine · 2019Review
- Fibrosis independent atrial fibrillation in older patients is driven by substrate leukocyte infiltration: diagnostic and prognostic implications to patients undergoing cardiac surgery.Journal of translational medicine · 2019Article
- Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation.Journal of clinical medicine · 2018Article
- Atrial Fibrillation in Hypertension: Patients' Characteristics.Materia socio-medica · 2018Article
- Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms.Frontiers in pharmacology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an unfavorable prognosis, increasing the risk of stroke and death. Although traditionally associated with cardiovascular diseases, there is increasing evidence of high incidence of AF in patients with highly prevalent noncardiovascular diseases, such as cancer, sepsis, chronic obstructive pulmonary disease, obstructive sleep apnea and chronic kidney disease. Therefore, considerable number of patients has been affected by these comorbidities, leading to an increased risk of adverse outcomes.The authors performed a systematic review of the literature aiming to better elucidate the interaction between these conditions.Several mechanisms seem to contribute to the concomitant presence of AF and noncardiovascular diseases. Comorbidities, advanced age, autonomic dysfunction, electrolyte disturbance and inflammation are common to these conditions and may predispose to AF.The treatment of AF in these patients represents a clinical challenge, especially in terms of antithrombotic therapy, since the scores for stratification of thromboembolic risk, such as the CHADS2 and CHA2DS2VASc scores, and the scores for hemorrhagic risk, like the HAS-BLED score have limitations when applied in these conditions.The evidence in this area is still scarce and further investigations to elucidate aspects like epidemiology, pathogenesis, prevention and treatment of AF in noncardiovascular diseases are still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.